Cencora, Inc. · NYSE:COR
Cencora — AmerisourceBergen — Q3 FY2021 Earnings Presentation
14 slides from Cencora's earnings presentation, Aug 4, 2021
Slide 1: Q3 FY2021 Financial Results
Q3 FY2021 Financial Results August 4, 2021
Slide 2: Cautionary note regarding forward-looking statements
Cautionary note regarding forward-looking statements Certain of the statements contained in this presentation are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Securit
Slide 3: AmerisourceBergen is united in our responsibility to create healthier futures
AmerisourceBergen is united in our responsibility to create healthier futures. AmerisourceBergen drives innovative partnerships with global manufacturers, providers, and pharmacies to improve product access and efficiency throughout the healthcare supply chain.
Slide 4: Overview
Overview Strong Q3 Differentiated value Fiscal 2021 performance proposition guidance update • Pharmaceutical • Industry-leading • Updated fiscal 2021 distribution growth customer base guidance reflects driven by solid • Leadership in strong performance performance across specialty across businesses
Slide 5: Q3 FY2021 financial results: Consolidated results
Q3 FY2021 financial results Consolidated results GAAP Adjusted (non-GAAP)1 Revenue $53.4B $53.4B % Change (Year-over-Year) 17.7% 17.7% Gross profit $1.9B $1.6B % Change 54.0% 32.0% Operating expenses $1,267M $996M % Change 54.4% 37.5% Operating income $621M $631M % Change 53.3% 24.3% Interest expens
Slide 6: Pharmaceutical Distribution Services segment
Q3 FY2021 financial results Pharmaceutical Distribution Services segment Q3 FY2021 Q3 FY2020 Revenue $49.3B $43.6B Operating income $484M $427M Percentages of revenue Gross profit 2.14% 2.08% Operating expenses 1.16% 1.10% Operating income 0.98% 0.98% ▪ Revenue increase of 13.2% driven by strong spe
Slide 7: Other — Global Commercialization Services, MWI Animal Health, and Alliance Healthcare
Q3 FY2021 financial results Other — Global Commercialization Services, MWI Animal Health, and Alliance Healthcare Q3 FY2021 Q3 FY2020 Revenue $4.1B $1.8B Operating income $147M $83M Percentages of revenue Gross profit 13.92% 18.17% Operating expenses 10.37% 13.59% Operating income 3.56% 4.58% ▪ Othe
Slide 8: FY2021 guidance
FY2021 guidance Updated guidance reflects continued strong performance across AmerisourceBergen’s businesses 1 Expectations on an adjusted (non-GAAP) basis2 Revenue At least $210B Diluted earnings per share $9.15 to $9.30 Operating expense ~$3.9B Operating income ~$2.6B Pharmaceutical Distribution S
Slide 9: Purpose fuels performance
Purpose fuels performance Why we exist We are united in our responsibility to create healthier futures Our key strengths Best customer base Leader in specialty Innovation mindset Corporate stewardship distribution and commercialization Our growth strategies Customer focus Expand on Execution and inn
Slide 10: Advancing environmental, social, and governance initiatives
Advancing environmental, social, and governance initiatives to create healthier futures around the world Environmental Social Governance Adapting to a Investing in our people Embracing a culture of changing climate and communities transparency, ethics, and integrity • Reduced greenhouse gas • COVID-
Slide 11: Appendix
AmerisourceBergen Appendix
Slide 12: Note: For more information related to non-GAAP financial measures, refer to the section titled
12 Note: For more information related to non-GAAP financial measures, refer to the section titled “Supplemental Information Regarding Non-GAAP Financial Measures” of the exhibit to the Company’s most recent Current Report on Form 8-K furnished under Item 2.02.
Slide 13: Note: For more information related to non-GAAP financial measures, refer to the section titled
Note: For more information related to non-GAAP financial measures, refer to the section titled “Supplemental Information Regarding Non-GAAP Financial Measures” of the exhibit to the 13 Company’s most recent Current Report on Form 8-K furnished under Item 2.02.
Slide 14: Contact
Contact Bennett S. Murphy Senior Vice President Investor Relations bmurphy@amerisourcebergen.com